US Patent 7935718 Treatment of dyskinesia
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+298 characters)
Article
Patent abstract
The present invention relates to the use of compounds that enhance H3-histamine receptor activity, or activation (e.g. H3-histamine receptor agonists) for the treatment of dyskinesia. The compounds are particularly useful for treating dyskinesia associated with parkinsonian therapy.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Alan Crossman0
Jonathan Brotchie0
Michael Hill0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07935718 Treatment of dyskinesia US Patent 7935718 Treatment of dyskinesia
Infobox
Patent Number
079357180
Patent Number
79357180
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079357180
Date of Patent
May 3, 2011
0Patent Application Number
109749800
Date Filed
October 28, 2004
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07935718 Treatment of dyskinesia
Infobox
Is a
Patent jurisdiction
Patent number
07935718
Date of patent
May 3, 2011
Patent application number
10974980
Date Filed
October 28, 2004
Patent primary examiner
Find more entities like US Patent 7935718 Treatment of dyskinesia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.